(c) 2024 PillSync.com

tacrolimus capsule

1 INDICATIONS AND USAGE Tacrolimus capsules are a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver, kidney or heart transplants, and pediatric patients receiving allogeneic liver transplants in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney, Liver, or Heart Transplant Tacrolimus capsules are indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant [see Clinical Studies ( 14.1 )] , liver transplant [see Clinical Studies ( 14.2 )] and heart transplant [see Clinical Studies ( 14.3 )] , and pediatric patients receiving allogeneic liver transplants [see Clinical Studies ( 14.2 )] in combination with other immunosuppressants. Additional pediatric use and lung transplant information is approved for Astellas Pharma US, Inc.’s Prograf (tacrolimus) products. However, due to Astellas Pharma US, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.

glenmark pharmaceuticals inc., usa


11 months ago CAPSULE WHITE G 686 tacrolimus capsule

CAPSULE WHITE G 686

11 months ago CAPSULE WHITE G 686 tacrolimus capsule

G 686 CAPSULE WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1

TACROLIMUS capsules, USP

TACROLIMUS capsules, USP are available as follows: 0.5 mg: Size “4” hard gelatin capsule with light yellow cap and light yellow body, imprinted with a Glenmark logo “G” on the cap and “685” on the body in red ink, filled with white to off-white granular powder. Bottles of 100 with child-resistant closure, NDC 68462-685-01 1 mg: Size “4” hard gelatin capsule with white cap and white body, imprinted with a Glenmark logo “G” on the cap and “686” on the body in red ink, filled with white to off-white granular powder. Bottles of 100 with child-resistant closure, NDC 68462-686-01 Cartons of 100 (10 x 10 unit-dose), NDC 68462-686-14 5 mg: Size “4” hard gelatin capsule with greyish red cap and greyish red body, imprinted with a Glenmark logo “G” on the cap and “687” on the body in white ink, filled with white to off-white granular powder. Bottles of 100 with child-resistant closure, NDC 68462-687-01 Cartons of 100 (10 x 10 unit-dose), NDC 68462-687-14 Note:

TACROLIMUS capsules, USP are not filled to maximum capsule capacity. capsule contains labeled amount. Store and Dispense Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. 16.4 Handling and Disposal

TACROLIMUS can cause fetal harm.

TACROLIMUS capsules should not be opened or crushed. Wearing disposable gloves is recommended during dilution of the injection in the hospital and when wiping any spills. Avoid inhalation or direct contact with skin or mucous membranes of the powder contained in

TACROLIMUS capsules. If such contact occurs, wash the skin thoroughly with soap and water; if ocular contact occurs, rinse eyes with water. In case a spill occurs, wipe the surface with a wet paper towel. Follow applicable special handling and disposal procedures 1 .


More pills like CAPSULE G 686

Related Pills

Tacrolimus 0.5 mg

glenmark pharmaceuticals inc., usa

tacrolimus capsule

glenmark pharmaceuticals inc., usa












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site